Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Executive VP and CFO/COO

President and CEO

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a peptide mimetic molecule with amino acid mimetic structure and amino acids properties; and L8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various dis...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-11	Premium	bought	Premium	Premium	Premium	-
2024-03-06	Premium	sold	Premium	Premium	Premium	-
2023-12-06	Premium	sold	Premium	Premium	Premium	Executive VP and CFO/COO
2023-12-04	Premium	sold	Premium	Premium	Premium	-
2023-08-15	Premium	sold (taxes)	Premium	Premium	Premium	Executive VP and CFO/COO
2023-08-15	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2023-06-20	Premium	acquired	Premium	Premium	Premium	Executive VP and CFO/COO
2023-06-20	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-20	Premium	acquired	Premium	Premium	Premium	-
2023-06-20	Premium	acquired	Premium	Premium	Premium	-
2023-06-20	Premium	acquired	Premium	Premium	Premium	-
2023-06-20	Premium	acquired	Premium	Premium	Premium	-
2023-06-20	Premium	acquired	Premium	Premium	Premium	-
2023-06-20	Premium	acquired	Premium	Premium	Premium	-
2022-12-27	Premium	bought	Premium	Premium	Premium	Executive VP and CFO/COO
2022-12-27	Premium	acquired	Premium	Premium	Premium	Executive VP and CFO/COO
2022-12-27	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-12-27	Premium	bought	Premium	Premium	Premium	President and CEO
2022-12-21	Premium	sold	Premium	Premium	Premium	-
2022-12-15	Premium	sold	Premium	Premium	Premium	Executive VP and CFO/COO
2022-12-15	Premium	sold	Premium	Premium	Premium	Executive VP and CFO/COO
2022-12-15	Premium	sold	Premium	Premium	Premium	President and CEO
2022-12-15	Premium	sold	Premium	Premium	Premium	President and CEO
2022-12-15	Premium	sold	Premium	Premium	Premium	President and CEO
2022-12-15	Premium	sold	Premium	Premium	Premium	President and CEO

PTN - Palatin Technologies Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for PTN